Raffles Medical: Can the Support Hold?

  • Post author:

Raffles Medical is currently testing the long term up trend support and also the neckline support of the Double Tops chart pattern.  This support level is at about $2.20.  Breaking down from the Double Tops may send Raffles Medical to price target of $2.05. Currently Raffles Medical PE ratio is 26.3 (base on $2.25) which is higher compare to Medical and BioTechnology sector average PE of 16.2.

  • PE (Rolling) = 25.5
  • PE (FY2010) = 26.3
  • PE (FY2009) = 31.4
  • PE (FY2008)  = 37.7
  • PE (FY2007) = 33.1

 

Fundamental Analysis (base on FY2010):

  • EPS = $0.08571
  • Net Operating Cash Flow = S$49.2 Million (Positive and Stable Net Operating Cash Flow for past 4 years)
  • Net Profit Margin: 18.9%
  • ROA = 12.2%
  • ROE = 15.8%
  • Current Ratio = 2.1
  • Debt to Equity Ratio = Debt Free

Fundamentally strong stock with stable earning and positive operating cash flow year over year. However, current stock price is not cheap for long term investment. Wait for the correction to accumulate.

Continue ReadingRaffles Medical: Can the Support Hold?

Cerebos Pacific: Can the Uptrend Continue?

  • Post author:

Cerebos Pacific is currently testing the 2 years uptrend support. Current PE of 10.8 (base on current price $4.98) is not over value compare to the sector average of about 15 and PE of previous years.

  • PE (FY2010) = 15.28
  • PE (FY2009) = 19.01
  • PE (FY2008)  = 19.43

Fundamental Analysis (base on FY2010):

  • EPS = $0.4607 (increasing for the past 3 years)
  • Net Operating Cash Flow = S$198.2 Million (increasing for the past 3 years)
  • Net Profit Margin: 12.2% (increasing for the past 3 years)
  • ROA = 19.2% (increasing for the past 3 years)
  • ROE = 33.3% (increasing for the past 3 years)
  • Current Ratio = 1.7
  • Debt to Equity Ratio = 0.28

Keep a close eye of the uptrend support and 200D MA support. Maybe good to accumulate for long term investment when the correction comes.

Continue ReadingCerebos Pacific: Can the Uptrend Continue?

Straits Asia Resources: Where is the Direction?

  • Post author:

Straits Asia Resources (SAR) failed to break the previous uptrend support turned resistance (green line) and also break down from the recent uptrend channel support (blue). Currently SAR is just sitting above the 50D MA support.

Is SAR starting a correction after a 5 months mini bull run? Level to watch:

  • Uptrend support turned resistance and 20D MA resistance at about $3.03.
  • 78.6% Fibonacci Support and 50D MA support at about $2.89.
  • 100D MA support at about $2.70.

The volatility of SAR stock price represents a good stock for short term trade in either direction.

Continue ReadingStraits Asia Resources: Where is the Direction?